Stress Management and Resiliency Training for Depression vs Treatment as Usual in the Treatment of Major Depression

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

27 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-12-18

Study Completion Date

2023-05-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Researchers are trying to find out if a Stress Management and Resiliency Training (SMART-D) therapy will help with major depression treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Stress Management and Resiliency Training (SMART) Integrated Into Treatment of Major Depression

NCT03275961

Depression

COMPLETED NA

Practicing Alternative Techniques to Heal From Depression: The PATH-D Study

NCT00871299

Major Depressive Disorder

COMPLETED NA

The S.M.A.R.T. Project: Stress Management and Resilience Training for Teens

NCT03270943

Depression Mild Resilience, Psychological Adolescent Behavior

COMPLETED NA

Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness

NCT05962879

Anxiety Disorders Psychotic Disorders Depressive Disorder +1 more

RECRUITING NA

Cognitive Control Training as an Adjunct to Behavioral Activation Therapy in the Treatment of Depression

NCT01694719

Depression

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Major Depression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SMART-D Intervention Group

Subjects will participate in Stress Management and Resiliency Training for Depression (SMART-D) therapy as well as treatment as usual which consists of any ongoing medication or psychotherapy based treatments that are currently in place.

Group Type EXPERIMENTAL

Stress Management and Resiliency Training for Depression (SMART-D) Therapy

Intervention Type BEHAVIORAL

6 SMART-D group therapy sessions over 8 weeks

Standard of Care Group

Treatment as usual will consist of any ongoing medication or psychotherapy based treatments that are currently in place.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Stress Management and Resiliency Training for Depression (SMART-D) Therapy

6 SMART-D group therapy sessions over 8 weeks

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants will be enrolled for this study from patients attending the Mayo Clinic Depression Center, Mayo Clinic Family Medicine clinics, Behavioral Health and Primary Care Clinic at Mayo Clinic Health System, Austin, MN, with a diagnosis of major depression, in partial or near remission with PHQ-9 scores ≤14
* Participants will be required to be between 25 and 80 years old
* Able to speak English
* Able to provide written informed consent to participate in the study
* Participants must have DSM-V diagnostic confirmation of major depressive disorder (MDD) (American Psychiatric Association 2013).
* Participants will continue taking any prescribed medications from their clinical treatment team.
* Participants with co-morbid secondary diagnoses of persistent depressive disorder and generalized anxiety disorders will be included in the study.
* Participants must consent to audio recording of random group sessions which will be disclosed at the final study session.

Exclusion Criteria

* Participants with bipolar disorder, active psychosis, active suicidal ideations, and active substance abuse meeting criteria for substance use disorders except nicotine, obsessive compulsive disorder, active panic disorder with agoraphobia or other phobic disorder, active posttraumatic stress disorder, active severe personality disorders will be excluded.
* Pregnant women - because of time duration of the study.

Minimum Eligible Age

25 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No